GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis
about
Constitutional and occupational risk factors associated with bladder cancerGenome-wide association study identifies multiple loci associated with bladder cancer riskGenome-wide interaction study of smoking and bladder cancer riskrs1495741 as a tag single nucleotide polymorphism of N-acetyltransferase 2 acetylator phenotype associates bladder cancer risk and interacts with smoking: A systematic review and meta-analysis.Review of the Gene-Environment Interaction Literature in Cancer: What Do We Know?Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data.The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysisLarge-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background.Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients.A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background.Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.The role of genotypes that modify the toxicity of chemical mutagens in the risk for myeloproliferative neoplasms.Prevalence of at-risk genotypes for genotoxic effects decreases with age in a randomly selected population in Flanders: a cross sectional study.Hair dye use and risk of bladder cancer in the New England bladder cancer study.Impact of urinary bladder cancer risk variants on prognosis and survival.The post GWAS era: strategies to identify gene-gene and gene-environment interactions in urinary bladder cancer.Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African Americans.Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice.Association of glutathione S-transferase T1 and M1 genotypes with chronic liver diseases among Filipinos.A prospective multicenter study on bladder cancer: the COBLAnCE cohort.GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysisInteraction of cigarette smoking and carcinogen-metabolizing polymorphisms in the risk of colorectal polyps.Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry.Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer.GSTT1 Null Genotype Significantly Increases the Susceptibility to Urinary System Cancer: Evidences from 63,876 Subjects.Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer developmentCYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese populationGenetic Variants in the Wnt/β-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk.Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.Combined Genetic Biomarkers Confer Susceptibility to Risk of Urothelial Bladder Carcinoma in a Saudi Population.Current status of genome-wide association studies in cancer.Glutathione S-transferase P1 gene polymorphism and bladder cancer susceptibility: an updated analysis.Toxicogenetic profile and cancer risk in Lebanese.Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis.Occupational risk factors for relapse-free survival in bladder cancer patients.Polymorphisms of xenobiotic metabolizing enzymes in bladder cancer patients of the Semmelweis University Budapest, Hungary.Improved genotyping of N-acetyltransferase 2: role of the ultra-slow acetylators.Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.Genetic variants confer susceptibility to urinary bladder cancer: an updated list of confirmed polymorphisms.
P2860
Q28585505-7F19F528-FED9-4979-9BE0-4F3F38555806Q28659283-362E22DF-65FC-47C4-8B2D-FB37C472816CQ28943359-49CE1CC7-014D-4E5D-B452-8B3E85B8F1D2Q30248611-C330F9F4-4AED-4831-9A40-508FE01A883FQ30251624-ABE22D2B-2B21-4B77-B979-97F0CD4ED004Q30732621-90585BF1-3168-4C1B-8668-76DCF85B7ED0Q33595451-9484C02C-5838-4F54-AB39-BC7E75364C55Q34125066-7837F1DF-20D6-40E9-BA3C-3A4B76955DDDQ34161803-3B769C8E-AF50-445B-A6F2-E2B24966F8B3Q34414220-DC683FF2-9425-4422-91AC-0A8DF9A8D6DDQ34532463-0DA466D0-58E7-4B83-B57E-D3804180087EQ35227976-3ED857EE-EAE6-4448-B2BD-A97944C3F0CCQ35373298-C81A9CBC-054D-4C3D-87C8-F95307851B75Q35464023-F89BA2A3-7CA2-4B5E-8336-E5B74B021634Q35717096-84D9F298-5561-46FA-8CEC-CD51E6DF47A7Q35729161-4DD1118F-E784-4C29-82CB-EE8791B79BFFQ35736809-CCFB8C98-2204-4ED3-8FFA-18AA7F85EF9EQ35830906-A7833944-88F8-4E8E-961C-46F27154167FQ36038286-7BED1694-C3EC-4D97-A2A6-BFDFB4696663Q36181457-0060DF00-C096-465C-A6FE-84DC289FFFADQ36211691-B356FB66-1E2C-4C22-A9D6-06A7CCBF1EEEQ36740734-591FB047-FA60-461A-931C-81A9C913CF4FQ36754771-DF2ED5CF-8597-444D-9E46-AD15D33B6939Q36940496-8D347941-E5D5-4240-90CF-217783CF7EECQ36944260-92CF851F-870D-418E-9E32-F619B43BB0C4Q37290556-C558AF5E-CFD8-4C21-AAAA-C96099721E53Q37329008-3DA13F55-FD9A-4260-AC7B-847E54F49FFDQ37367212-14C207B6-28A9-4898-80CE-2C94B86074CEQ37380438-81B2C853-F11E-4446-BFBB-176C3E154549Q37457764-D906C3CF-7DBA-42E7-A34B-C239C2A28560Q37699997-7746F4B7-CE5F-4E81-9AE3-23DE24D4F7ADQ37890286-740FFE82-8403-43E4-B141-8EE17744F3D6Q38051088-1B1B53CC-79DB-499C-9043-905525B1FEBAQ38195853-8E3CCE97-14CD-4676-A54D-F61C7009B867Q38399984-1C81A8AE-9553-42B8-A015-460D2E01040AQ38404020-87DB3D5E-AA03-4442-B4C8-DE4860BDE4D2Q38684214-C73DCE24-899C-4EBD-8D11-09F5831C1742Q39336687-840614D7-DABC-469D-AD20-413F567DB364Q42708451-B57A9E2B-EB5B-4A35-8366-9BD4CE84E243Q42769306-E87A7EED-6C26-4110-A07C-84F773EBB1D9
P2860
GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
GSTM1 null and NAT2 slow acety ...... r study and NAT2 meta-analysis
@ast
GSTM1 null and NAT2 slow acety ...... r study and NAT2 meta-analysis
@en
GSTM1 null and NAT2 slow acety ...... r study and NAT2 meta-analysis
@nl
type
label
GSTM1 null and NAT2 slow acety ...... r study and NAT2 meta-analysis
@ast
GSTM1 null and NAT2 slow acety ...... r study and NAT2 meta-analysis
@en
GSTM1 null and NAT2 slow acety ...... r study and NAT2 meta-analysis
@nl
prefLabel
GSTM1 null and NAT2 slow acety ...... r study and NAT2 meta-analysis
@ast
GSTM1 null and NAT2 slow acety ...... r study and NAT2 meta-analysis
@en
GSTM1 null and NAT2 slow acety ...... r study and NAT2 meta-analysis
@nl
P2093
P2860
P50
P356
P1433
P1476
GSTM1 null and NAT2 slow acety ...... r study and NAT2 meta-analysis
@en
P2093
A R Schned
A T Johnson
C L Dagnall
D T Silverman
K P Cantor
P2860
P304
P356
10.1093/CARCIN/BGQ223
P407
P577
2010-10-29T00:00:00Z